Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The goal of this clinical trial is to evaluate whether both Form H and Form II, 100mg brincidofovir tablets are bioequivalent, when given under fasting conditions in healthy adults. Participants will be randomized to each receive one tablet of Form H and one tablet of Form II,14 days apart and undergo pharmacokinetic testing pre-dose and post-dose to evaluate safety. This is an open-label, single-dose, randomized, two-period, crossover study.
Epistemonikos ID: 3aed90736de9f56d2a3b0216fbaf42206403c8aa
First added on: Oct 02, 2023